We are changing the molecular diagnostic paradigm to bring the tests close to you
Bloodstream infections: less than 10 CFU/ml from whole blood;
COVID-19: detect 250 viral copies/ml
One-hour sample to results directly from whole blood. 30 minutes sample to results directly from swab
A simple design and optimized manufacturing process provide low cost
No DNA/RNA extraction required
We are currently developing a number of assays that work on the GeneSpark platform.
In Clinical Development
In Development
Follow up with GeneSpar’s latest news, please subscribe here.